Church & Dwight Company, Inc.   Report issue

For profit Phase 3 Phase 4
Founded: Trenton NJ United States (1846)
Status: No NME R&D (1846)

Organization Overview

First Clinical Trial
2007
NCT00474175
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Church & Dwight Company, Inc. | Director, Global Product Safety & Clinical Affairs Church & Dwight Co., Inc.